20/20: NSERC Ophthalmic Materials Network
Skip to content
Home
About 20/20
20/20 Governance
Network Researchers
Network Partners
Clinical Advisors
Glossary
À propos de 20/20
Research
Objectives
Projects
Useful Links
Events
Students
News
Contact Us
Main Menu
Home
About 20/20
Research
Objectives
Projects
Useful Links
Events
Students
News
Contact Us
Members Only
Username or email
Password
Remember me
Forgot login?
Useful Links
Display #
5
10
15
20
25
30
50
100
All
#
Web Link
1
Ophthalmic drug products approved by the FDA for over-the counter use
The OTC Ophthalmic monograph details what components can be used and in what concentrations to produce OTC ophthalmic products in the US.
2
The cost of vision loss in Canada - June 2009 [pdf]
The CNIB and Canadian Ophthalmological Society's landmark study measures the true cost of vision loss in Canada and its impact on governments, employers and all Canadians.
3
20/20 Model Drug - Ciprofloxacin (RxList)
Information about 20/20 model drug, ciprofloxacin, from RxList.com
4
20/20 Model Drug - Ciprofloxacin (Wikipedia)
Information about 20/20 model drug, ciprofloxacin, from Wikipedia
5
20/20 Model Drug - Timolol (RxList)
Information about 20/20 model drug, Timolol (Betimol), from RxList.com
6
20/20 Model Drug - Timolol (Wikipedia)
Information about 20/20 model drug, Timolol (Betimol), from Wikipedia
7
20/20 Model Drug - Dexamethasone (RxList)
Information about 20/20 model drug, dexamethasone, from RxList.com
8
20/20 Model Drug - Dexamethasone (Wikipedia)
Information about 20/20 model drug, dexamethasone, from Wikipedia
9
20/20 Model Drug - Avastin (RxList)
Information about 20/20 model drug, Avastin (Bevacizumab), from RxList.com
10
20/20 Model Drug - Avastin (Wikipedia)
Information about 20/20 model drug, Avastin (Bevacizumab), from Wikipedia
You are here:
Home
Research
Useful Links
Upcoming Events
31.03.2010 - 01.04.2010
20/20 2010 Spring Annual Conference
02.05.2010 - 06.05.2010
ARVO 2010
06.10.2010 - 07.10.2010
20/20 2010 Fall Annual Conference
Latest News
47 attend the June 23rd 20/20 meeting
23.07.09